Skip to main content

Day: July 8, 2025

Willis launches $200m facility to tackle global geopolitical uncertainty for cargo owners

Undercover is a market-first insurance solution for cargo owners facing increasing geopolitical risk LONDON, July 08, 2025 (GLOBE NEWSWIRE) — Willis, a WTW business (NASDAQ: WTW), has launched ‘Undercover’, a new $200 million facility, combining coverage for a range of geopolitical exposures faced by cargo owners worldwide. Developed by Willis in a joint proposition with specialist insurer, Markel, Undercover offers a unique approach to the risk transfer of cargo, war on land, terrorism, political violence and confiscation coverage, with sections of coverage selected based on the individual needs of the client. This single-facility approach minimizes coverage gaps and reduces the likelihood of claims disputes, as well as removing the need to establish the motivation for a claim. In challenging times of political instability, Undercover...

Continue reading

Liquidity Services Announces Third Quarter Fiscal Year 2025 Earnings Conference Call

BETHESDA, Md., July 08, 2025 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT), a leading global commerce company powering the circular economy, today announced that it expects to report its third quarter fiscal year 2025 results prior to market open on Thursday, August 7, 2025. Bill Angrick, Chairman and CEO, and Jorge Celaya, EVP and CFO, will then host a conference call to review the results at 10:30 AM Eastern Time. To participate in the conference call, please register here to receive the dial-in number and unique conference pin. A listen-only live webcast of the conference call will also be provided on the Company’s investor relations site. An archive of the webcast will be available on the Company’s website until August 7, 2026. To listen to the replay, visit the Liquidity Services investor relations site. The replay will...

Continue reading

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

– NDA assigned a Target Action Date of February 25, 2026 –– Product has patent protection through 2044 – DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the Company’s New Drug Application (NDA) for ET-600, a proprietary patented formulation of desmopressin oral solution, has been accepted for review by the U.S. Food and Drug Administration (FDA) and has been assigned a Prescription Drug User Fee Act (PDUFA) target action date of February 25, 2026. “We are thrilled to be one step closer to bringing ET-600 to patients and addressing another significant unmet need within the pediatric endocrinology community. Currently,...

Continue reading

Dundee Precious Metals Announces Preliminary Second Quarter Production Results and Timing of Second Quarter Financial Results

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) — Dundee Precious Metals (“DPM” or the “Company”) announced preliminary production results for the three and six months ended June 30, 2025. “We continue to deliver solid, consistent results from our operations, with gold and copper production increasing in the second quarter as planned,” said David Rae, President and Chief Executive Officer. “Both mines are on track to achieve our 2025 guidance and are well-positioned to continue our strong operating track record.” Production Highlights Preliminary results for the second quarter and first half of 2025 are provided in the table below:  Ore processed Metals contained in concentrate produced Payable metals in concentrate sold  (Kt) Gold(K oz.) Copper(Mlbs.) Gold(K oz.) Copper(Mlbs.)Q2 2025          Chelopech 541.1 47.0 6.4 38.4 5.2Ada...

Continue reading

Castellum and AmpliTech Group Announce Execution of Reseller Agreement

VIENNA, Va., July 08, 2025 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (the “Company” and “Castellum”) and AmpliTech Group, Inc. (Nasdaq: AMPG) (“AmpliTech”) are pleased to jointly announce that the Company’s newly formed product subsidiary, Castellum Advanced Technology Products, Inc., has entered into a reseller agreement (the “Reseller Agreement”) with AmpliTech to resell AmpliTech’s products to Castellum’s clients. “We are thrilled to partner with AmpliTech and be able to resell AmpliTech’s products, including their world-class low noise amplifiers,” said Glen Ives, Chief Executive Officer of Castellum. “Arrangements such as this one are exactly why we recently established our new subsidiary, Castellum Advanced Technology Products, Inc., to both partner with great companies such...

Continue reading

TopBuild to Acquire Progressive Roofing in All-Cash Transaction Valued at $810 Million, Creating a New Growth Platform

Aligns with TopBuild’s Core Strengths Expands Building Envelope Installation Solutions to IncludeComprehensive Suite of Commercial Roofing Services Enables Significant Growth Potential in ~$75B Highly Fragmented, Largely Non-Discretionary Commercial Roofing Services Industry DAYTONA BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) —  TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, announced that it has entered into an agreement to acquire Progressive Roofing, a portfolio company of Bow River Capital, for $810 million in cash. This represents approximately 9.1x Progressive’s earnings before interest, taxes, depreciation and amortization (EBITDA) for the trailing twelve months ended March 31, 2025,...

Continue reading

Prosafe SE: Share capital decrease completed

8 July 2025 – Reference is made to the stock exchange announcement made by Prosafe SE (the “Company“) on 16 May 2025 regarding the extraordinary general meeting’s resolution to decrease the share capital of the Company by EUR 22,157,127.24, from EUR 22,335,813.75 to EUR 178,686.51, through a decrease of the nominal value of each share in the Company by EUR 1.24, from EUR 1.25 to EUR 0.01. The resolution was published by the Norwegian Register of Business Enterprises on 22 May 2025 and followed by a six-week creditor notice period, which was completed without creditor objections. The share capital decrease has today been registered as completed by the Norwegian Register of Business Enterprises. Following the share capital decrease, the share capital of the Company is EUR 178,686.51, divided into 17,868,651 shares,...

Continue reading

CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right

SAN CARLOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) — CARGO Therapeutics, Inc. (“CARGO” or the “Company”) (NASDAQ: CRGX), a biotechnology company that has focused on developing CAR T-cell therapies, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with Concentra Biosciences, LLC (“Concentra”), whereby Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, par value $0.001 per share (“CARGO Common Stock”), plus one non-transferable contingent value right (“CVR”), which represents the right to receive: (i) 100% of the closing net cash of CARGO in excess of $217.5 million; and (ii) 80% of any net proceeds received within two years following closing from any disposition of certain of CARGO’s product candidates that occurs within two years following closing, each...

Continue reading

Porsche reports U.S. retail sales for the first half of 2025

Robust demand leads to all-time half year recordPorsche reports U.S. retail sales for the first half of 2025A significant sales increase was posted by the PanameraPorsche reports U.S. retail sales for the first half of 2025Robust demand leads to all-time half year recordAtlanta., July 08, 2025 (GLOBE NEWSWIRE) — Porsche Cars North America, Inc. (PCNA) today announced that second-quarter retail deliveries in the United States totaled 19,812 vehicles, up 4.91 percent from the first quarter of 2025.  Porsche maintained an H1 increase of 11.4 percent over the same period in 2024 making it the best half year in PCNA history. “Despite a volatile market, our sales remained strong and interest in our cars continued to grow, in large part because of the outstanding customer experience delivered by our Porsche Centers,”...

Continue reading

Aurora Mobile Partners with HashNut to Advance Stablecoin Adoption for Web3 Payments and Broader Use Cases

SHENZHEN, China, July 08, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced a strategic partnership with HashNut, a leading crypto payment solution provider. This collaboration will drive the adoption of stablecoins for Web3 payments and digital applications, advancing the global circulation and commercialization of digital assets. Aurora Mobile has already begun integrating HashNut’s Web3 payment system into several products targeting Southeast Asia and global markets. This move will enable annual stablecoin settlement volumes – including USDT and USDC – to reach several million US dollars. Leveraging HashNut’s technological expertise in on-chain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.